Please login to the form below
migraine
This page shows the latest migraine news and features for those working in and with pharma, biotech and healthcare.
Amgen and Novartis migraine drug hits the mark again
Amgen and Novartis migraine drug hits the mark again. Aimovig will become the first CGRP receptor-targeting drug if it reaches market. ... In the control group just under 14% of patients achieved a 50% reduction in migraine days.
Latest news
-
EMA set to review Teva’s migraine injection
EMA set to review Teva’ s migraine injection. Fremanezumab could be approved for prophylactic use of migraines. ... The European Medicines Agency (EMA) has accepted Teva’s marketing authorisation application (MAA) for its migraine prevention medicine
-
UCB supports social network for SpA patients
lupus, eczema, migraines and HIV to name a few.
-
Lilly axes 3,500 jobs in $500m-a-year cost-cutting drive
hoping to add to its portfolio with new therapies for breast cancer ( abemaciclib) and migraine ( galcanezumab).
-
FDA knocks-back second Vernalis cough and cold treatment
for the acute treatment of migraines.
-
Race to CGRP migraine drug finish line enters the final straight
Some patients have seen their migraines completely eradicated with the new drugs - something that has never been seen before in chronic migraine therapy. ... a 100% reduction in monthly migraine day at month 15 - will give it a highly competitive profile.
More from news
Approximately 15 fully matching, plus 120 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2018
III CGRP antibody for the treatment of migraine.
-
The good, the bad and the ugly
Three CGRP monoclonal antibodies will launch in the US for migraine in 2018 - with a fourth anticipated in 2019.
-
The cultural construction of illness
Some years ago, we were asked to advise on marketing a cure for migraines in the UK. ... In this world, migraines were associated with ideas of the overly sensitive, or even hysterical woman, requiring rational male intervention to bring her back to her
-
Ditch the data?
Around one in seven people suffer from migraines, and these can impact severely on quality-of-life. ... When a migraine hits, she needs to shut herself in a dark room in silence.
-
Deal Watch January 2017
1, 000. CoLucid. Lilly. Company acquisition. Lasmiditan for the acute treatment of migraine.
More from intelligence
Approximately 2 fully matching, plus 21 partially matching documents found.
Latest appointments
-
Newron Pharma appoints commercial affairs VP
He brings sales and marketing experience from Johnson &Johnson, and served as franchise marketing director for psychiatry, Parkinson's disease and migraine products at Novartis.
-
Red Door Unlimited appoints new digital strategy head
Prior to joining the agency, Morgan worked on accounts in patient advocacy for cancer immunotherapy, hepatitis C treatments and migraines for Firstlight PR and Hill and Knowlton Strategies.
-
Zogenix appoints Pfizer’s R Scott Shively as chief commercial officer
operations. This includes ensuring the success of current products, such as Sumavel DosePro for migraine, as well as soon to be launched products, such as Zohydro, which is pending FDA approval
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Double Communiqué award win for 90TEN
The Migraine Unlocked campaign took a surround-sound communications approach using advertising, media and grassroots campaigning to maximise exposure to sufferers and their loved ones. ... Commenting on Migraine Unlocked, t he Comm uniqué judges said:
-
What it takes to win at Cannes Health Lions
As for Martin, DDB Remedy won a Silver and Two bronze awards for an integrated campaign for Excedrin, an OTC migraine treatment in the US, helping to address the issue that ... people often respond to someone with a migraine by just saying that it’ s
-
90TEN nominated for five Communique Awards including Small Consultancy of the Year
The Allergan “ Migraine Unlocked” campaign is a finalist in Excellence in Communications via a Live Event or Stand-Alone Activity, and an HCV programme for AbbVie has been recognised in the
-
Double Communiqué award win for 90TEN
The Migraine Unlocked campaign took a surround-sound communications approach using advertising, media and grassroots campaigning to maximise exposure to sufferers and their loved ones. ... Commenting on Migraine Unlocked, t he Comm uniqué judges said:
-
What it takes to win at Cannes Health Lions
As for Martin, DDB Remedy won a Silver and Two bronze awards for an integrated campaign for Excedrin, an OTC migraine treatment in the US, helping to address the issue that ... people often respond to someone with a migraine by just saying that it’ s
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
Featured jobs
-
Senior Programme Executive
-
Salary TBC
- Account Manager – Med Comms – London
-
Salary TBC
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
-
Senior Medical Writer
-
Great salary and bebefits
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
-
Senior Medical Writer
-
Great salary and benefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Scientific Director
-
Great salary and bebefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
Subscribe to our email news alerts
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- No incentive for a cure
- The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
Quick links
Infographics
